Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDC42EP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KRT17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ST6GAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGFBP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EGR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HCG26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507461 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-DPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCN3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIK3AP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCL17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OTUD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM65B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on